Evidence map›Paper›PMID 33135728›Full record

ArticleThe Journal of clinical endocrinology and metabolism2021

Brown Fat-Activating Lipokine 12,13-diHOME in Human Milk Is Associated With Infant Adiposity.

Danielle Wolfs, Matthew D Lynes, Yu-Hua Tseng, Stephanie Pierce, Valerie Bussberg, Abena Darkwah, Vladimir Tolstikov, Niven R Narain, Michael C Rudolph, Michael A Kiebish and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Gut-X axis.iMeta · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Danielle WolfsDepartment of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts.
Matthew D LynesDepartment of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts.
Yu-Hua TsengDepartment of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts.
Stephanie PierceDepartment of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Valerie BussbergBERG, Framingham, Massachusetts.
Abena DarkwahBERG, Framingham, Massachusetts.
Vladimir TolstikovBERG, Framingham, Massachusetts.
Niven R NarainBERG, Framingham, Massachusetts.
Michael C RudolphDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Michael A KiebishBERG, Framingham, Massachusetts.
Ellen W DemerathDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota.
David A FieldsDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota.
Elvira IsganaitisDepartment of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts.
Framingham State University · USJoslin Diabetes Center · USUniversity of Minnesota · USUniversity of Oklahoma Health Sciences Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Maternal Obesity, Milk Composition, and Infant GrowthR01HD080444 · NICHD · UNIVERSITY OF MINNESOTA · PI ELLEN W. DEMERATH, DAVID A FIELDS · 2014 to 2026
$6.4M
Role of BMPs in Adipogenesis, Mitochondrial Function and Energy MetabolismR01DK077097 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2007 to 2019
$5.6M
Fibroblast Growth Factor and Energy MetabolismR01DK102898 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2015 to 2024
$4.1M
The Lipidomics of Adipose Tissue ThermogenesisK01DK111714 · NIDDK · MAINEHEALTH · PI LYNES, MATTHEW D · 2017 to 2021
$804k
Early Life Fatty Acid Exposures Dictate Obesity PredispositionK01DK109079 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RUDOLPH, MICHAEL C. · 2017 to 2021
$686k
Early Life n-3 Fatty Acids Increase Novel Adipogenesis-Regulatory Cells to Condition Adipogenesis in a NR2F2 Dependent MannerR03DK122189 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RUDOLPH, MICHAEL C. · 2019 to 2020
$225k
NICHD NIH HHS R01 HD080444NIDDK NIH HHS K01 DK109079NIDDK NIH HHS K01 DK111714NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK077097NIDDK NIH HHS R01 DK102898NIDDK NIH HHS R03 DK122189
6 · The paper itself

Abstract

contextLittle is known about the specific breastmilk components responsible for protective effects on infant obesity. Whether 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME), an oxidized linoleic acid metabolite and activator of brown fat metabolism, is present in human milk, or linked to infant adiposity, is unknown.

objectiveTo examine associations between concentrations of 12,13-diHOME in human milk and infant adiposity.

designProspective cohort study from 2015 to 2019, following participants from birth to 6 months of age.

settingAcademic medical centers.

participantsVolunteer sample of 58 exclusively breastfeeding mother-infant pairs; exclusion criteria included smoking, gestational diabetes, and health conditions with the potential to influence maternal or infant weight gain.

main outcome measuresInfant anthropometric measures including weight, length, body mass index (BMI), and body composition at birth and at 1, 3, and 6 months postpartum.

resultsWe report for the first time that 12,13-diHOME is present in human milk. Higher milk 12,13-diHOME level was associated with increased weight-for-length Z-score at birth (β = 0.5742, P = 0.0008), lower infant fat mass at 1 month (P = 0.021), and reduced gain in BMI Z-score from 0 to 6 months (β = -0.3997, P = 0.025). We observed similar associations between infant adiposity and milk abundance of related oxidized linoleic acid metabolites 12,13-Epoxy-9(Z)-octadecenoic acid (12,13-epOME) and 9,10-Dihydroxy-12-octadecenoic acid (9,10-diHOME), and metabolites linked to thermogenesis including succinate and lyso-phosphatidylglycerol 18:0. Milk abundance of 12,13-diHOME was not associated with maternal BMI, but was positively associated with maternal height, milk glucose concentration, and was significantly increased after a bout of moderate exercise.

conclusionsWe report novel associations between milk abundance of 12,13-diHOME and adiposity during infancy.

Indexed as

AdiposityAdipose Tissue, BrownAdultBody CompositionBody Mass IndexBreast FeedingFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleMassachusettsMilk, HumanOleic AcidsPediatric Obesity12,13-dihydroxyoctadecenoic acidOleic Acids1213-diHOMEbreastmilkbrown fat activatorsinfant adiposityinfant metabolismthermogenic metabolites

Identifiers

PMID33135728
PMCPMC7823229
OpenAlexW3096079295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.